0001493152-21-001407.txt : 20210120 0001493152-21-001407.hdr.sgml : 20210120 20210120104143 ACCESSION NUMBER: 0001493152-21-001407 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210120 EFFECTIVENESS DATE: 20210120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enveric Biosciences, Inc. CENTRAL INDEX KEY: 0000890821 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 954484725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386795 FILM NUMBER: 21537660 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: 239-302-1707 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 FORMER COMPANY: FORMER CONFORMED NAME: AMERI Holdings, Inc. DATE OF NAME CHANGE: 20150527 FORMER COMPANY: FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC DATE OF NAME CHANGE: 19950323 D 1 primary_doc.xml X0708 D LIVE 0000890821 Enveric Biosciences, Inc. 4851 TAMIAMI TRAIL N SUITE 200 NAPLES FL FLORIDA 34103 239-302-1707 DELAWARE Spatializer Audio Laboratories Inc AMERI Holdings, Inc. SPATIALIZER AUDIO LABORATORIES INC Corporation true John Van Buiten 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Financial Officer David Johnson 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Director Chief Executive Officer and Chairman Avani Kanubaddi 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Executive Officer Chief Operations Officer George Kegler 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Sol Mayer 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Marcus Schabacker 4851 Tamiami Trail N Suite 200 Naples FL FLORIDA 34103 Director Pharmaceuticals Decline to Disclose 06b false 2021-01-12 true true true false 0 8249959 0 8249959 Represents warrants to purchase up to 1,666,019 shares of common stock at an exercise price of $4.9519 per share. false 6 0 0 0 false Enveric Biosciences, Inc. /s/ John Van Buiten John Van Buiten Chief Financial Officer 2021-01-20